Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000378:metabolism*; D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000378:metabolism*; D000818:Animals; D002147:Calmodulin / Q000494:pharmacology; D006152:Cyclic GMP / Q000494:pharmacology; D004176:Dipyridamole / Q000494:pharmacology; D066298:In Vitro Techniques; D007700:Kinetics; D007938:Leukemia / Q000201:enzymology*; D007939:Leukemia L1210 / Q000201:enzymology; D008214:Lymphocytes / Q000201:enzymology*; D051379:Mice; D008811:Mice, Inbred DBA; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology
D002147:Calmodulin; D010726:Phosphodiesterase Inhibitors; D004176:Dipyridamole; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D006152:Cyclic GMP